Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma.
about
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104.Epidermal growth factor receptor in pancreatic cancer.EGF receptor-targeted therapy in non-small-cell lung cancer: role of germline polymorphisms in outcome and toxicity.[Effects of EGFR gene polymorphisms on efficacy and prognosis in advanced non-small cell lung cancer treated with EGFR-TKIs].
P2860
Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Epidermal growth factor recept ...... in pancreatic adenocarcinoma.
@ast
Epidermal growth factor recept ...... in pancreatic adenocarcinoma.
@en
type
label
Epidermal growth factor recept ...... in pancreatic adenocarcinoma.
@ast
Epidermal growth factor recept ...... in pancreatic adenocarcinoma.
@en
prefLabel
Epidermal growth factor recept ...... in pancreatic adenocarcinoma.
@ast
Epidermal growth factor recept ...... in pancreatic adenocarcinoma.
@en
P2093
P2860
P1476
Epidermal growth factor recept ...... in pancreatic adenocarcinoma.
@en
P2093
Andrew V Kossenkov
Andrey Frolov
Ching-Wei D Tzeng
J Pablo Arnoletti
J Spencer Liles
Martin J Heslin
Mohamad Eloubeidi
Nirag Jhala
Peter Kulesza
Shyam Varadarajulu
P2860
P304
P356
10.1016/J.AMJSURG.2009.10.014
P407
P577
2010-04-21T00:00:00Z